Q3 2016 Holdings
Filed 2016-11-14 | 9 holdings | $51.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $51.0M | 965,369 | 99.4% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $155.9K | 12,682,876 | 0.3% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $66.7K | 4,806,656 | 0.1% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $46.6K | 3,455,316 | 0.1% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $23.5K | 1,651,862 | 0.0% |
| T2 Biosystems Inc | COM | 89853L104 | $15.8K | 2,176,167 | 0.0% |
| Eleven Biotherapeutics Inc | COM | 286221106 | $6.6K | 2,354,710 | 0.0% |